PSEN1 and Alzheimer disease: Thus, in a few animal studies conducted in the mice model for AD, supplementation with SAM as the methyl donor modulates the methylation in PSEN1, which leads to not only restoring the methylation potential but also losing the symptoms linked with AD (48, 49).